Clearing the way for ribozymes

Nature Biotechnology

Volumn 15, Issue 5, 1997, Pages 414-415

  Burke, John M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; ARTICLE; CHEMISTRY; ESCHERICHIA COLI; GENE THERAPY; GENETIC ENGINEERING; GENETIC PROCEDURES; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAMMAL; METABOLISM; TRANSGENIC ANIMAL; TRANSGENIC PLANT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ESCHERICHIA COLI; GENE THERAPY; GENETIC ENGINEERING; GENETIC TECHNIQUES; HIV; HUMANS; MAMMALS; PLANTS, GENETICALLY MODIFIED; RNA, CATALYTIC;

EID: 0031137957     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0597-414     Document Type: Article

References (7)

1. Chen, H., Ferbeyre, G., and Cedergren, R. 1997. Nature Biotechnology 15:432-435.
2. Eckstein, F. and Lilley, D.M.J., (eds). 1996. Nucleic Acids and Molecular Biology, Vol. 10. Springer Verlag, Berlin.
3. Jensen, K.H. 1988. Eur. J. Biochem. 175:587-593.
4. Ueber A. and Strauss, M. 1995. Mol. Cell. Biol. 15:540-551.
5. Good, P.D. et al. 1997. Gene Ther. 4:45-54.
6. Jarvis, T.C. et al. 1996. J. Biol. Chem. 271:29107-29112.
7. Sullenger, B.A. 1995. Appl. Biochem. Biotechnol. 54:57-61.